P53 gene therapy for pulmonary metastasis tumor from hepatocellular carcinoma

Anti-Cancer Drugs

Volumn 21, Issue 9, 2010, Pages 882-884

  Yu, Miao ^a   Chen, Wei ^a   Zhang, Jinshan ^b  

^a 301 Military General Hospital   (China)

^b General Military Hospital   (China)

Author keywords

gene therapy; hepatocellular carcinoma; p53; pulmonary metastasis

Indexed keywords

ADENOVIRUS VECTOR; GENDICINE; PROTEIN P53;

ADULT; ADVANCED CANCER; AGED; ARTICLE; ARTIFICIAL EMBOLISM; CANCER GENE THERAPY; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; DISEASE EXACERBATION; DRUG EFFICACY; DRUG INFUSION; DRUG SAFETY; FEMALE; FEVER; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LUNG METASTASIS; MALE; PRIORITY JOURNAL; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SYMPTOM; TREATMENT RESPONSE; TUMOR GROWTH; VIRUS RECOMBINANT;

ADENOVIRIDAE; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; EMBOLIZATION, THERAPEUTIC; FEMALE; FOLLOW-UP STUDIES; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 77956397834     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/CAD.0b013e32833db1bb     Document Type: Article

References (11)

1. Hofseth LJ, Hussain SP, Harris CC. p53: 25 years after its discovery. Trends Pharmacol Sci 2004; 25:177-181.
2. Achisn M, Hupp TR. Hypoxia attenuates the p53 response to cellular damage. J Oncogene 2003; 22:3431-3440.
3. Balint E, Vousden KH. Activation and activities of the p53 tumor suppressor protein. J Br Cancer 2002; 85:1813-1823.
4. Frank DK. Intrgen advexin therapy halts tumor growth in advanced esophageal cancer patients. J News Release 2003; 6:2-8.
5. Liu BW, Chen JJ. Medical molecular biology. Beijing: Chinese Academy of Medical Sciences & Peking Union Medical College Press; 2000, pp. 490-494.
6. Swisher SG, Roth JA. Clinical update of Ad-p53 gene therapy for lung cancer. Surg Oncol Clin N Am 2002; 11:521-535.
7. Roth JA, Grammer SF. Gene replacement therapy for non-small-cell lung cancer: a review. Hematol Oncol Clin North Am 2004; 18:215-229.
8. Geng T, Jiliang L, Hongsong D. Experimental study of p53 gene on the inhibition of human s hepatocellular carcinoma cells. Shengzhen Chin West Med Integra Mag 2007; 17:286-290.
9. Guan YS, Liu Y, Zhou XP, Li X, He Q, Sun L. p53 gene (gendicine) and embolisation overcame recurrent hepatocellular carcinoma [J]. Gut 2005; 54:1318-1319.
10. Pan JJ, Zhang SW, Chen CC, Xiao SW, Sun Y, Liu CQ, et al. Effect of recombinant adenovirus-p53 combined with radiotherapy on long-term prognosis of advanced nasopharyngeal carcinoma. J Clin Oncol 2009; 27:799-804.
11. Zhang S, Li Y, Li L, Zhang Y, Gao N, Zhang Z, Zhao H. Phase I study of repeated intraepithelial delivery of adenoviral p53 in patients with dysplastic oral leukoplakia. Oral Maxillofac Surg 2009; 67:1074-1082.